Filing Details
- Accession Number:
- 0001104659-21-099742
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-04 06:06:41
- Reporting Period:
- 2021-08-03
- Accepted Time:
- 2021-08-04 06:06:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1790340 | Immuneering Corp | IMRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1870076 | Peter Feinberg | C/O Immuneering Corporation, 245 Main Street, Second Floor Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-08-03 | 133,572 | $0.00 | 257,325 | No | 4 | C | Indirect | See Foonote |
Class A Common Stock | Acquisiton | 2021-08-03 | 129,167 | $15.00 | 386,492 | No | 4 | P | Indirect | See Foonote |
Class A Common Stock | Acquisiton | 2021-08-03 | 123,155 | $0.00 | 347,401 | No | 4 | C | Indirect | See Foonote |
Class A Common Stock | Acquisiton | 2021-08-03 | 129,167 | $15.00 | 476,568 | No | 4 | P | Indirect | See Foonote |
Class A Common Stock | Acquisiton | 2021-08-03 | 82,108 | $0.00 | 82,108 | No | 4 | C | Indirect | See Foonote |
Class A Common Stock | Acquisiton | 2021-08-03 | 33,333 | $15.00 | 115,441 | No | 4 | P | Indirect | See Foonote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See Foonote |
No | 4 | P | Indirect | See Foonote |
No | 4 | C | Indirect | See Foonote |
No | 4 | P | Indirect | See Foonote |
No | 4 | C | Indirect | See Foonote |
No | 4 | P | Indirect | See Foonote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Series A Preferred Stock | Disposition | 2021-08-03 | 102,926 | $0.00 | 102,926 | $0.00 |
Class A Common Stock | Series A Preferred Stock | Disposition | 2021-08-03 | 92,509 | $0.00 | 92,509 | $0.00 |
Class A Common Stock | Series A Preferred Stock | Disposition | 2021-08-03 | 51,462 | $0.00 | 51,462 | $0.00 |
Class A Common Stock | Series B Preferred Stock | Disposition | 2021-08-03 | 30,646 | $0.00 | 30,646 | $0.00 |
Class A Common Stock | Series B Preferred Stock | Disposition | 2021-08-03 | 30,646 | $0.00 | 30,646 | $0.00 |
Class A Common Stock | Series B Preferred Stock | Disposition | 2021-08-03 | 30,646 | $0.00 | 30,646 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
- Mr. Feinberg is a General Partner of PF Associates L.P.
- Mr. Feinberg is a General Partner of PEF LLC.
- Mr. Feinberg is a General Partner of S4K Investments LLC.